期刊文献+

艾普拉唑治疗老年十二指肠溃疡疗效观察 被引量:10

下载PDF
导出
摘要 目的探讨艾普拉唑治疗老年十二指肠溃疡的疗效与安全性。方法将老年十二指肠溃疡患者220例随机分为2组,治疗组110例予艾普拉唑肠溶片10 mg口服1次/d,对照组110例予兰索拉唑片30 mg口服1次/d。2组疗程均为4周。停药后复查内镜观察溃疡愈合情况,记录症状改善及不良反应情况。结果治疗组与对照组的疼痛消失时间分别为(1.34±0.50)d和(2.30±1.30)d,2组比较有显著性差异(P<0.05)。2组间的总有效率、4周溃疡愈合率、症状消失率比较均无显著性差异(P均>0.05)。治疗组的不良反应较对照组少。结论艾普拉唑对老年十二指肠溃疡有较高的治愈率和症状改善率,疗效与兰索拉唑相当,用药后患者疼痛消失时间短于兰索拉唑,不良反应较兰索拉唑少。
作者 王平 陈渭
出处 《现代中西医结合杂志》 CAS 2013年第7期763-764,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献7

二级参考文献19

  • 1本刊编辑部.未来4000万孤寡老年妇女的养老问题怎么办?[J].人口研究,2001,25(5):50-59. 被引量:10
  • 2张林,王江滨.CYP2C19与质子泵抑制剂[J].国外医学(消化系疾病分册),2004,24(3):166-169. 被引量:11
  • 3Kim EJ, Lee RK, Kim DY, et al. General pharmacology of IY- S1149: a new proton pump inhibitor. Arzneiminelforschung, 2001,51:51-59.
  • 4Kwon D, Chae JB, Park CW, et al. Effects of IY-81149:a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Arzneimittelforschung, 2001,51:204-213.
  • 5Goldwater R, Boileau F, Lee SM, et al. A phase Ⅰ randomized, parallel, placebo-controlled, safety, tolerance and pharmacokinetie study of single ascending doses of IY-81149 in fasting male volunteers. Clinical Pharmacology & Therapeutics, 1999, 65 : 126.
  • 6Sakai T, Aoyama N, Kita T, et al. CYP2C19 genotype and pharmacokinetics of three proton pmp inhibitors in healthy subj ects. Pharm Res, 2001, 18:721-727.
  • 7Klok RM,Postma M J, van Hout BA,et al. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment Pharmacol Ther, 2003, 17:1237-1245.
  • 8Kwon D, Chae JB, Park CW, et al.Effects of IY - 81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo [ J ]. Arzneimittelforschung, 2001,51 (3) :204.
  • 9Kim E J, Lee RK, Lee SM, et al. General pharmacology of IY - 81149, a new proton pump inhibitor [ J ]. Arzneimittelforschung , 2001,51 ( 1 ) : 51.
  • 10Kil BJ, Kim IW, Shin CY, et al. Comparison of IY81149 with omeprazole in rat reflux oesophagitis [ J ], Auton Pharmacol, 2000,20(5 - 6) :291.

共引文献119

同被引文献65

  • 1吴小平.胆汁反流性胃炎[J].中级医刊,1993,28(6):8-9. 被引量:7
  • 2林江,陶红,岑敏,张建英,江波,熊东亮,臧宁,杨振发.纯西药与中西医结合方案治疗幽门螺旋杆菌致十二指肠溃疡的疗效比较[J].广州医学院学报,2006,34(1):60-61. 被引量:9
  • 3Klok R,M,Postma MJ,van Hour BA,et aI.Mefa--analysis:comparingthe efficacy of proton pump fnhibitors in short--term use[J].Aliment Pharmacol Ther,2013,17:1 237-1245.
  • 4Lf Y,Zhang W,Guo D,et aI.PharmacokineWcs of the new proton pump inhibitor ilaprazole in Chinese healthy subjec% in relation"OYP 34, 5 and CYP 2CI 9 genotypes[J].Olin Chim Acta,20;2,391:60-67.
  • 5Wang L, Zhou L, Lin S, et al.A new PP1, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial[J].J Clin Gastroenterol, 2011, 45 ( 4 ) : 322-329.
  • 6Ho K Y, Kuan A, Zano F, et al.Randomized, parallel, double- blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers[J].J Gastroenterol, 2009, 44 ( 7 ) : 697-707.
  • 7Sachs G, Shin J M, Howden C W.Review article: the clinical pharmacology of proton pump inhibitors[J].Aliment Pharmacol Ther, 2006, 23 ( suppl 2 ) : 2-8.
  • 8Shi S, Klotz U.Proton pump inhlbitors: an update of their clinical use and pharmacokinetics[J].Eur J Clin Pharmacol, 2008, 64 ( 10 ) : 935-951.
  • 9Kwon D, Chae J B, Park C W, et al.Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo[J].Arzneimittelforschung, 2001, 51 ( 3 ) : 204-213.
  • 10Li Y, Zhang W, Guo D, ct al.Pharmacokinetics of the new proton pump inhibitor ilaprazole in chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypea[J].Clin Chim Acta, 2008, 391 ( 1/2 ) : 60-67.

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部